Tag Archives: anti-depressant

Open‐label study with the monoamine stabilizer (‐)‐OSU6162 [drug] in ME/CFS

Posted on 02/18/2021 by wames

Open‐label study with the monoamine stabilizer (‐)‐OSU6162 in myalgic encephalomyelitis/ chronic fatigue syndrome, by Sara Haghighi, Sara Forsmark, Olof Zachrisson, Arvid Carlsson, Marie K L Nilsson, Maria L Carlsson, Robert C Schuit, Carl‐Gerhard Gottfries in Brain and Behavior, 02 February … Continue reading →

Posted in News | Tagged , , , , , , , , , , , | Comments Off on Open‐label study with the monoamine stabilizer (‐)‐OSU6162 [drug] in ME/CFS

Seroxat study under-reported harmful effects on young people

Posted on 09/24/2015 by wames

Seroxat study under-reported harmful effects on young people, say scientists, by Sarah Boseley Health editor in Guardian online, Wednesday 16 September 2015 Experts who re-analysed data say study is still referred to in medical literature and needs to be retracted. An … Continue reading →

Posted in News | Tagged , , | Comments Off on Seroxat study under-reported harmful effects on young people

Duloxetine – little effect on general fatigue but helps mental fatigue in CFS

Posted on 01/08/2015 by wames

Research abstract Objective: To assess the efficacy and safety of duloxetine in patients with chronic fatigue syndrome. Methods: A 12-week, randomized, double-blind study was designed to compare duloxetine 60-120 mg/day (n=30) with placebo (n=30) for efficacy and safety in the … Continue reading →

Posted in News | Tagged , , , , , | Comments Off on Duloxetine – little effect on general fatigue but helps mental fatigue in CFS